Establishes age- and gender-specific blood pressure goals for pediatric patients with primary aldosteronism (PA) using published normative data to assess treatment adequacy and avoid over-treatment. Use when managing hypertension in children with PA to evaluate if BP is adequately controlled; triggers include pediatric PA hypertension, BP not normalized with glucocorticoid therapy, and need for age‑specific BP targets.
Installs into .claude/skills of the current project.
Are you the author of Esa Pa Pediatric Bp Target?
Add the live security badge to your README. It updates with every re-scan.
[](https://www.skillsdirectory.com/skills/dromlakhani-esa-pa-pediatric-bp-target)
---
name: esa-pa-pediatric-bp-target
description: Establishes age- and gender-specific blood pressure goals for pediatric patients with primary aldosteronism (PA) using published normative data to assess treatment adequacy and avoid over-treatment. Use when managing hypertension in children with PA to evaluate if BP is adequately controlled; triggers include pediatric PA hypertension, BP not normalized with glucocorticoid therapy, and need for age‑specific BP targets.
---
# Determine Blood Pressure Targets for Children with PA
## STEP 1 — Gather Information
Collect patient age (years), sex, height (or BMI), weight, current systolic/diastolic BP, glucocorticoid type and dose, confirmation of PA (e.g., GRA genotype or clinical diagnosis), and any comorbidities. → Proceed to STEP 2.
## STEP 2 — Rule In / Rule Out
Determine if the patient is a child (<18 years) with confirmed PA requiring glucocorticoid therapy; if not, the skill does not apply (stop). If yes, proceed to STEP 3.
## STEP 3 — Classify or Stratify
Using age‑, sex‑, and height‑specific normative BP tables (e.g., NIH childhood BP percentiles), calculate the 90th percentile systolic and diastolic BP as the treatment target; if height unavailable, use age‑sex 90th percentile from population norms. → Proceed to STEP 4.
## STEP 4 — Decide
If current BP ≤ target, maintain current glucocorticoid dose; if current BP > target, consider increasing glucocorticoid dose (weight‑adjusted) or adding an MR antagonist, then re‑evaluate BP in 2–4 weeks. → End.
## Clinical Guardrails / Mimics / Pitfalls
Avoid excessive glucocorticoid dosing that can cause growth retardation, cushingoid features, or adrenal suppression; do not apply adult BP thresholds (140/90 mmHg) to children; ensure normative data match the child's ethnicity and height; monitor for hypokalemia when adding MR antagonist; do not ignore weight‑based glucocorticoid adjustments.
## Concrete Clinical Example
9‑year‑old girl with GRA on prednisone 5 mg daily, BP 128/82 mm Hg, height 130 cm (50th percentile). Age‑sex‑height 90th percentile BP is 115/72 mm Hg; current BP exceeds target, so increase prednisone to 7.5 mg daily and recheck BP in 3 weeks.
**Source:** The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-4061
> **TODO:** consider adding scripts/calc.py for the esa-pa-pediatric-bp-target calculator